Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Reitan Ribeiro is a leading gynecologic oncologist whose research has fundamentally reshaped the surgical treatment of early-stage cervical cancer. His most transformative contribution is his central role in the landmark LACC Trial, a phase III randomized study that compared minimally invasive radical hysterectomy (laparoscopic or robotic) with the traditional open abdominal approach. The trial’s startling results, published in the *New England Journal of Medicine* (2018, with over 1,850 citations), demonstrated that minimally invasive surgery was associated with significantly lower rates of disease-free survival and overall survival, leading to a dramatic global shift in clinical practice away from the then-dominant robotic and laparoscopic techniques. Dr. Ribeiro has further advanced the field through his leadership of the International Radical Trachelectomy Assessment Study (IRTA), which evaluates fertility-sparing surgery for young women with early-stage disease. His work also includes pioneering techniques such as robotic uterine transposition to preserve fertility in patients requiring pelvic radiation. With a body of work that has directly altered surgical guidelines and sparked intense debate, Dr. Ribeiro stands as a pivotal figure in evidence-based gynecologic oncology.